HNGE
Hinge Health, Inc.Company with tickers: HNGE
CIK
1673743
CUSIP
433313103
Shares Outstanding
54,655,926
Website
https://www.hingehealth.com
Investor Relations
https://ir.hingehealth.com/overview/default.aspx
13F Activity (30d)
6 filings
4 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$250,000,000
as of 2025-11-10
Remaining Authorization
$80,000,000
as of 2026-03-31
Program Utilization
68.0%
$170,000,000 used of $250,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-03-31 YTD | $104,966,000 | 10-Q, filed 2026-05-07 | ||
| 2025-12-31 | $65,028,000 | 10-K, filed 2026-03-03 | ||